Clínica Baviera, S.A. (BME:CBAV)
Spain
· Delayed Price · Currency is EUR 50.80
-0.80 (-1.55%)
At close: Mar 5, 2026
Clínica Baviera Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 826 | 796 | 499 | 375 | 284 | 346 | Upgrade
|
| Market Cap Growth | 51.56% | 59.55% | 33.02% | 31.81% | -17.69% | 50.35% | Upgrade
|
| Enterprise Value | 847 | 819 | 529 | 376 | 286 | 360 | Upgrade
|
| Last Close Price | 51.60 | 49.70 | 30.28 | 21.43 | 15.70 | 18.36 | Upgrade
|
| PE Ratio | 20.00 | 18.92 | 12.41 | 10.42 | 9.64 | 12.62 | Upgrade
|
| Forward PE | - | 23.87 | 23.87 | 23.87 | 23.87 | 23.87 | Upgrade
|
| PS Ratio | 2.71 | 2.61 | 1.88 | 1.65 | 1.43 | 2.00 | Upgrade
|
| PB Ratio | 7.45 | 7.17 | 5.07 | 4.06 | 4.16 | 6.24 | Upgrade
|
| P/TBV Ratio | 11.82 | 11.39 | 8.33 | 5.09 | 5.44 | 8.86 | Upgrade
|
| P/FCF Ratio | 17.78 | 17.12 | 13.86 | 10.67 | 7.23 | 9.53 | Upgrade
|
| P/OCF Ratio | 10.80 | 10.41 | 7.98 | 6.49 | 5.33 | 7.38 | Upgrade
|
| PEG Ratio | - | 2.19 | 2.19 | 2.19 | 2.19 | 2.19 | Upgrade
|
| EV/Sales Ratio | 2.78 | 2.69 | 1.99 | 1.66 | 1.44 | 2.08 | Upgrade
|
| EV/EBITDA Ratio | 10.01 | 9.69 | 7.00 | 5.66 | 5.04 | 6.75 | Upgrade
|
| EV/EBIT Ratio | 13.95 | 13.51 | 9.51 | 7.52 | 6.82 | 9.13 | Upgrade
|
| EV/FCF Ratio | 18.21 | 17.63 | 14.70 | 10.71 | 7.27 | 9.93 | Upgrade
|
| Debt / Equity Ratio | 0.63 | 0.63 | 0.62 | 0.51 | 0.70 | 0.93 | Upgrade
|
| Debt / EBITDA Ratio | 0.83 | 0.83 | 0.81 | 0.71 | 0.84 | 0.96 | Upgrade
|
| Debt / FCF Ratio | 1.50 | 1.50 | 1.70 | 1.35 | 1.21 | 1.42 | Upgrade
|
| Net Debt / Equity Ratio | 0.17 | 0.17 | 0.24 | -0.03 | 0.14 | 0.35 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.23 | 0.23 | 0.31 | -0.04 | 0.16 | 0.36 | Upgrade
|
| Net Debt / FCF Ratio | 0.42 | 0.42 | 0.66 | -0.07 | 0.24 | 0.53 | Upgrade
|
| Asset Turnover | 1.33 | 1.33 | 1.36 | 1.38 | 1.40 | 1.36 | Upgrade
|
| Inventory Turnover | 46.59 | 46.59 | 46.27 | 49.67 | 47.16 | 47.03 | Upgrade
|
| Quick Ratio | 0.90 | 0.90 | 0.84 | 1.18 | 1.01 | 1.00 | Upgrade
|
| Current Ratio | 0.97 | 0.97 | 0.95 | 1.28 | 1.09 | 1.06 | Upgrade
|
| Return on Equity (ROE) | 41.02% | 41.02% | 43.16% | 45.73% | 48.72% | 55.70% | Upgrade
|
| Return on Assets (ROA) | 16.51% | 16.51% | 17.82% | 19.03% | 18.47% | 19.36% | Upgrade
|
| Return on Invested Capital (ROIC) | 34.59% | 34.34% | 38.62% | 44.22% | 40.86% | 38.50% | Upgrade
|
| Return on Capital Employed (ROCE) | 32.60% | 32.60% | 34.50% | 37.50% | 38.50% | 40.30% | Upgrade
|
| Earnings Yield | 5.09% | 5.29% | 8.06% | 9.59% | 10.38% | 7.92% | Upgrade
|
| FCF Yield | 5.62% | 5.84% | 7.22% | 9.37% | 13.83% | 10.50% | Upgrade
|
| Dividend Yield | 3.04% | - | 5.19% | 7.33% | 8.28% | 5.61% | Upgrade
|
| Payout Ratio | 62.78% | 62.78% | 62.39% | 36.26% | 56.89% | 62.62% | Upgrade
|
| Buyback Yield / Dilution | -1.89% | -1.89% | 1.85% | - | - | -0.01% | Upgrade
|
| Total Shareholder Return | 1.24% | -1.89% | 7.04% | 7.33% | 8.28% | 5.60% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.